Portfolio Company · Operating Co.

Gencove

Low-pass genome sequencing
Gencovebacked byLewis & Clark Partners
CurrentLow-pass genome sequencing

Company Snapshot

Gencove is a low-pass genome sequencing portfolio company held by Lewis & Clark Partners. Profile compiled from public sources; submit updates to extend the public record.

SectorLow-pass genome sequencing
Ownership statusCurrent
Website

Ownership Context

Gencove is a current portfolio company of Lewis & Clark Partners. Public coverage of this company is grouped under its parent firm's profile.

Sources

https://lewisandclarkpartners.com/portfolio
This profile is based on publicly available information and may be incomplete or outdated. PE Firm Index is not affiliated with Gencove and does not provide investment advice.

Other portfolio companies of Lewis & Clark Partners

See the full Lewis & Clark Partners portfolio.